BANK OF MONTREAL /CAN/ - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,000
-99.8%
400
-99.2%
0.00%
-100.0%
Q3 2015$444,000
+76.9%
52,540
+129.4%
0.00%
Q2 2015$251,000
-45.9%
22,905
-31.0%
0.00%
-100.0%
Q1 2015$464,000
-70.3%
33,201
-64.1%
0.00%
-50.0%
Q4 2014$1,561,000
+10306.7%
92,384
+7598.7%
0.00%
Q2 2014$15,000
-96.2%
1,200
-96.4%
0.00%
Q1 2014$395,000
-51.4%
33,200
-43.5%
0.00%
-100.0%
Q4 2013$812,00058,8000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 6,575,000$21,237,0002.26%
AIGH Capital Management LLC 1,650,256$5,330,0001.12%
BVF INC/IL 8,383,645$27,079,0001.02%
GUARDIAN POINT CAPITAL, LP 1,200,000$3,876,0000.97%
Tri Locum Partners LP 1,210,863$3,911,0000.97%
Altium Capital Management LP 972,327$3,141,0000.87%
Worth Venture Partners, LLC 387,141$1,250,0000.61%
DAFNA Capital Management LLC 459,260$1,483,0000.35%
SABBY MANAGEMENT, LLC 530,000$1,712,0000.33%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 173,110$559,0000.24%
View complete list of INFINITY PHARMACEUTICALS INC shareholders